GENinCode (GENI) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 May 2022 07:00 AM
RNS
Notice of Results
06 Apr 2022 07:00 AM
RNS
Director Appointment
23 Mar 2022 07:00 AM
RNS
Indiana University Medical School collaboration
15 Mar 2022 07:00 AM
RNS
Lipid inCode pilot
21 Feb 2022 01:17 PM
RNS
Confirmation of board appointment
08 Feb 2022 07:00 AM
RNS
Positive results for Lipid inCode in NHS study
21 Jan 2022 07:00 AM
RNS
Proposed independent directorate appointment
10 Jan 2022 07:00 AM
RNS
FDA Pre-Submission for Cardio inCode-SCORE
29 Nov 2021 07:00 AM
RNS
Directorate Change
25 Nov 2021 07:00 AM
RNS
Trading update
17 Sep 2021 10:38 AM
RNS
Grant of Share Options and PDMR dealing
16 Sep 2021 07:00 AM
RNS
Half-year Report
10 Sep 2021 07:00 AM
RNS
Holding(s) in Company
02 Sep 2021 07:00 AM
RNS
Notice of Results
27 Jul 2021 09:27 AM
RNS
Holding(s) in Company
26 Jul 2021 07:00 AM
RNS
Positive Thrombo inCode clinical results
23 Jul 2021 04:04 PM
RNS
Holding(s) in Company
23 Jul 2021 09:53 AM
RNS
Holding(s) in Company
22 Jul 2021 07:00 AM
RNS
Admission to trading on AIM & First Day of Dealing

GENinCode is a predictive genetics biotechnology company that does genomic testing, AI bioinformatics and clinical algorithms to assess and prevent cardiovascular disease, thrombosis, familial hypercholesterolemia and ovarian cancer.

GENinCode share price is listed in London under the ticker GENI.

UK 100

Latest directors dealings